Saturday, March 15th, 2025

Novavax COVID-19 vaccine 89% effective in UK trials


29 January 2021  

Time taken to read : < 1 Minute


  • A
  • A
  • A

LONDON: A new coronavirus vaccine has shown 89.3% efficacy in large-scale UK trials.

The Novavax jab is the first to show it is effective against the new variant of the virus discovered in the UK, BBC reported.

Meanwhile, the UK has secured 60 million doses of the jab, which will be made in Stockton-on-Tees.

The doses are expected to be delivered in the second half of this year, if approved for use by the Medicines and Healthcare Products Regulatory Agency (MHRA), authorities said.

The UK has so far approved three coronavirus vaccines for emergency use – one from Oxford University and AstraZeneca, another by Pfizer and BioNTech, and a third from drug firm Moderna.

(With inputs from BBC)

Publish Date : 29 January 2021 07:25 AM

FSU election process stalled in 11 TU constituent campuses

KATHMANDU: The Free Students Union (FSU) election process has come

Two dead in tipper accident in Tinkune

KATHMANDU: Two people died in a tipper accident at Tinkune,

17 plays from 12 countries to be showcased at 3rd NITFest

KATHMADU: The third edition of the Nepal International Theatre Festival

G7 urges Russia to accept ceasefire or face further sanctions

CANADA: Top diplomats from the Group of Seven leading democracies

Westerly and local winds affecting Nepal’s weather

KATHMANDU: The country is currently experiencing partial influence from westerly